MSC Therapy Attenuates Obliterative Bronchiolitis after Murine Bone Marrow Transplant

Abstract

Rationale: Obliterative bronchiolitis (OB) is a significant cause of morbidity and mortality after lung transplant and hematopoietic cell transplant. Mesenchymal stromal cells (MSCs) have been shown to possess immunomodulatory properties in chronic inflammatory disease.